Vitamin D Repletion for Deficiency (17 ng/mL)
For an adult with a serum 25-hydroxyvitamin D level of 17 ng/mL, initiate cholecalciferol (vitamin D3) 50,000 IU once weekly for 8–12 weeks, followed by maintenance therapy with 800–2,000 IU daily. 1
Understanding the Deficiency Severity
- A level of 17 ng/mL is classified as vitamin D deficiency (< 20 ng/mL), requiring active treatment to prevent secondary hyperparathyroidism, bone demineralization, and increased fracture risk. 1, 2, 3
- This level falls well below the minimum target of 30 ng/mL needed for optimal bone health, fall prevention, and fracture risk reduction. 1, 4, 3
- Severe deficiency (< 10 ng/mL) warrants 12 weeks of loading; moderate deficiency (10–20 ng/mL) typically requires 8 weeks. 1
Loading Phase Protocol
Cholecalciferol (vitamin D3) is strongly preferred over ergocalciferol (vitamin D2) because it maintains serum 25(OH)D concentrations longer and has superior bioavailability, particularly with intermittent (weekly) dosing. 1, 4
- Standard regimen: 50,000 IU cholecalciferol once weekly for 8 weeks (for levels 10–20 ng/mL). 1, 2
- If the patient has symptoms (bone pain, proximal muscle weakness) or high fracture risk, consider extending to 12 weeks. 1
- The total cumulative dose over 8 weeks is 400,000 IU, which typically raises 25(OH)D by approximately 40–70 nmol/L (16–28 ng/mL), bringing most patients to at least 28–40 ng/mL. 1
Maintenance Phase
After completing the loading regimen, transition to maintenance therapy to sustain levels ≥ 30 ng/mL:
- Daily option: 800–2,000 IU cholecalciferol daily. 1, 2
- Monthly option: 50,000 IU cholecalciferol once monthly (equivalent to approximately 1,600 IU daily). 1
- For elderly patients (≥ 65 years), a minimum of 800 IU daily is recommended, though higher doses (700–1,000 IU daily) more effectively reduce fall and fracture risk. 1
Essential Co-Interventions
Adequate calcium intake is critical for optimal response to vitamin D therapy and PTH suppression:
- Ensure 1,000–1,500 mg calcium daily from diet plus supplements if needed. 1, 4
- Calcium supplements should be taken in divided doses of no more than 600 mg at once for optimal absorption. 1
Monitoring Protocol
- Recheck 25(OH)D levels 3 months after completing the loading phase to allow levels to plateau and confirm adequate response. 1, 4
- If using intermittent dosing (weekly or monthly), measure levels just prior to the next scheduled dose. 1
- Target level: ≥ 30 ng/mL for anti-fracture efficacy; some experts recommend 30–40 ng/mL for optimal health benefits. 1, 4, 3
- Upper safety limit: 100 ng/mL. 1
- Once stable and in target range, annual reassessment is sufficient. 1
Critical Pitfalls to Avoid
- Do not use active vitamin D analogs (calcitriol, alfacalcidol, doxercalciferol, paricalcitol) to treat nutritional vitamin D deficiency, as they bypass normal regulatory mechanisms and increase hypercalcemia risk. 1, 4
- Avoid underdosing with standard 400 IU daily supplements, which are grossly inadequate for correcting deficiency. 4
- Avoid single ultra-high loading doses (> 300,000 IU) as they may be inefficient or potentially harmful. 1
- Do not assume compliance—poor adherence is a common reason for inadequate response; verify adherence before increasing doses. 1
Special Populations
Chronic Kidney Disease (CKD Stages 3–4)
- Use standard nutritional vitamin D (cholecalciferol or ergocalciferol), not active analogs, for patients with GFR 20–60 mL/min/1.73 m². 1, 4
- CKD patients are at particularly high risk due to reduced sun exposure, dietary restrictions, and urinary losses. 1
Malabsorption Syndromes
- For patients with inflammatory bowel disease, post-bariatric surgery, or other malabsorptive conditions, consider intramuscular vitamin D3 50,000 IU if oral supplementation fails to achieve target levels. 1
- When IM is unavailable, use substantially higher oral doses: 4,000–5,000 IU daily for 2 months. 1
Expected Response
- Using the rule of thumb, an intake of 1,000 IU vitamin D daily increases serum 25(OH)D by approximately 10 ng/mL, though individual responses vary due to genetic differences in vitamin D metabolism. 1
- The standard 50,000 IU weekly regimen for 8 weeks should bring the level from 17 ng/mL to at least 28–40 ng/mL if the patient is responding normally. 1
Safety Profile
- Daily doses up to 4,000 IU are generally safe for adults, with some evidence supporting up to 10,000 IU daily for several months without adverse effects. 1
- Toxicity typically only occurs with prolonged daily doses exceeding 10,000 IU or serum levels > 100 ng/mL. 1, 5
- Symptoms of toxicity include hypercalcemia, hyperphosphatemia, suppressed PTH, and hypercalciuria. 1, 5